Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | Chief Operating Officer | March 22, 2023 | March 24, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date March 22, 2023 · Filed March 24, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 204,880 |
Reported balance
After 2023-03-22 transaction · row 1
1 source rowRow 1 · 2023-03-22 · Exercise / conversion · Acquired 50,000 · Balance 204,880 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.42 · Expires 2023-07-01 | Direct | 0 |
Reported balance
After 2023-03-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-22 · Exercise / conversion · Disposed 50,000 · Balance 0 F1: 25% of the 50,000 shares underlying the options vested in an annual installment on July 1, 2014 and the remaining balance vested in equal monthly installments until the option vested in full on July 1, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the 50,000 shares underlying the options vested in an annual installment on July 1, 2014 and the remaining balance vested in equal monthly installments until the option vested in full on July 1, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2020 Filed May 5, 2020 23:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,338 | $26.10 | $87,121.80 |
DisclosureSEC source: 0001562180-20-003397 · primarydocument.xml · nonDerivative · entry 3 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.85 to $26.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 7,412 | $25.07 | $185,818.84 |
DisclosureSEC source: 0001562180-20-003397 · primarydocument.xml · nonDerivative · entry 2 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,338 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $24.85 to $25.83, inclusive. Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 10,750 | $6.24 | $67,080.00 |
DisclosureSEC source: 0001562180-20-003397 · primarydocument.xml · nonDerivative · entry 1 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,750 | $0.00 Strike: $6.24 | $0.00 |
DisclosureSEC source: 0001562180-20-002901 · primarydocument.xml · derivative · entry 5 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 10,750 shares Expires 2024-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 37,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on May 13, 2018. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 4,734 | $27.20 | $128,764.80 |
DisclosureSEC source: 0001562180-20-002901 · primarydocument.xml · nonDerivative · entry 4 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F4 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $26.91 to $27.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 5,416 | $26.32 | $142,549.12 |
DisclosureSEC source: 0001562180-20-002901 · primarydocument.xml · nonDerivative · entry 3 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,734 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.91 to $26.89, inclusive. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 600 | $25.20 | $15,120.00 |
DisclosureSEC source: 0001562180-20-002901 · primarydocument.xml · nonDerivative · entry 2 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,150 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $24.90 to $25.78, inclusive. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 10,750 | $6.24 | $67,080.00 |
DisclosureSEC source: 0001562180-20-002901 · primarydocument.xml · nonDerivative · entry 1 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,750 | $0.00 Strike: $6.24 | $0.00 |
DisclosureSEC source: 0001562180-20-002259 · primarydocument.xml · derivative · entry 4 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,750 Underlying: Common Stock · 10,750 shares Expires 2024-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 37,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on May 13, 2018. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,228 | $29.24 | $65,146.72 |
DisclosureSEC source: 0001562180-20-002259 · primarydocument.xml · nonDerivative · entry 3 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $28.92 to $29.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 8,522 | $28.34 | $241,513.48 |
DisclosureSEC source: 0001562180-20-002259 · primarydocument.xml · nonDerivative · entry 2 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,228 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $27.92 to $28.91, inclusive. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 10,750 | $6.24 | $67,080.00 |
DisclosureSEC source: 0001562180-20-002259 · primarydocument.xml · nonDerivative · entry 1 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 02:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000056 · primarydocument.xml · nonDerivative · entry 1 Horstmeier Paul · CIK 0001780978 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2020 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.